Nalaganje...
Angiotensin receptor blockers in heart failure after the ELITE II trial
Specific blockers of the angiotensin type1 receptor, angiotensin receptor blockers (ARBs), have been introduced as an alternative to angiotensin-converting enzyme inhibitors (ACEi) for the treatment of heart failure. In comparison with ACEi, ARBs are better tolerated and have similar effects on haem...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2000
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC59604/ https://ncbi.nlm.nih.gov/pubmed/11714415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cvm-1-2-079 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|